Loading...
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies
Despite their nearly universal activation of mammalian target of rapamycin (mTOR) signaling, glioblastomas (GBMs) are strikingly resistant to mTOR-targeted therapy. We analyzed GBM cell lines, patient-derived tumor cell cultures, and clinical samples from patients in phase 1 clinical trials, and fin...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3600508/ https://ncbi.nlm.nih.gov/pubmed/23440206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1217602110 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|